Pharma-Bio Serv Q1 2023 revenue $4.2M (-$0.8M YoY); net income $0.4M (+$0.1M YoY)

Pharma-Bio Serv, Inc.

Quarterly revenue $4.2M, down from $5.0M in prior-year quarter.
Net income $0.4M, compared to $0.3M in same period last year.
CEO cites resource optimization in profitable markets driving gross profit improvement.
Company plans to continue maximizing resources to increase profitability.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Pharma-Bio Serv, Inc. reported quarter ended January 31, 2023 results: revenue approximately $4.2 million, net income approximately $0.4 million.

Period: quarter ended January 31, 2023
Revenue: approximately $4.2 million
Net income: approximately $0.4 million
Result: reported results

Exact text from the filing

revenues for the quarter ended January 31, 2023 were approximately $4.2 million, a net decrease of approximately $0.8 million when compared to the same period last year. Net income for the quarter ended January 31, 2023 was approximately $0.4 million, an increase of approximately $0.1 million when compared to the same period last year.

View on SEC.gov

308 earnings releases filed in the last 30 days. Browse all earnings releases →

Pharma-Bio Serv, Inc. filing history →

Source: SEC EDGAR

accession 0001654954-23-003136

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.